Join the Postoperative Pain group to help and get support from people like you.
Postoperative Pain News
Femoral Nerve Block Cuts Opioid Use in ACL Reconstruction
MONDAY, April 8, 2024 – For patients undergoing anterior cruciate ligament (ACL) reconstruction, a femoral nerve block (FNB) is associated with a lower incidence of excessive opioid consumption than...
Cosmetic Surgery Leaves 1 in 8 Patients With Chronic Post-Op Pain
WEDNESDAY, March 13, 2024 – Norwegians are increasingly asking surgeons for a nip, tuck or implant, and many — especially men — have pain that lingers long after their procedure, a new survey shows. ...
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain
BOSTON--(BUSINESS WIRE)--Jul. 19, 2021-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has begun a Phase 2 proof-of-concept (POC) study in acute pain following b...
You Can Safely Avoid Addictive Long-Acting Opioids After Knee Replacement
FRIDAY, March 8, 2024 – It's well known that long-acting opioid meds raise the odds for addiction in users – including folks dealing with pain after an orthopedic surgery. Now, new research...
Heron Therapeutics Announces FDA Approval of Zynrelef Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
SAN DIEGO, Jan. 23, 2024 /PRNewswire/ – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (the "FDA") has...
Recent Reduction Seen in Opioid Prescribing by Surgeons
THURSDAY, Jan. 18, 2024 – Opioid prescribing by surgeons decreased between 2013 and 2017, according to a study published online Jan. 16 in the Journal of the American College of Surgeons. Apostolos ...
You're Far Less Likely to Get an Opioid Now After Surgery
MONDAY, Dec. 11, 2023 – In response to the ongoing crisis of opioid misuse, U.S. doctors had already cut the amount of opioids they gave patients after surgery by 2022 to just a third of the amount...
2016 to 2022 Saw Drop in Rate of Opioid Prescriptions From Surgeons
THURSDAY, Dec. 7, 2023 – From 2016 to 2022, there was a decrease in the rate and size of opioid prescriptions from U.S. surgeons, according to a research letter published online Dec. 7 in JAMA...
Pacira Announces FDA Approval of Expanded Exparel Label to Include Two Additional Nerve Block Indications
Exparel is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — New indications for use as an adductor c...
ASA: Deep Learning Model Can Improve Pain Assessment
FRIDAY, Oct. 27, 2023 – An automated pain recognition system is promising for detecting pain before, during, and after surgery, according to a study presented at ANESTHESIOLOGY 2023, the annual...
Surgery Soon? Use These 3 Tips to Manage Post-Surgical Pain
SUNDAY, Sept. 10, 2023 – When someone has surgery, pain may be top of mind. An expert in managing post-op pain offers three tips for keeping it under control, safely. “Pain can inhibit recovery, but ...
ChatGPT May Provide Helpful Postoperative Instructions
MONDAY, May 1, 2023 – ChatGPT provides helpful postoperative instructions for families of pediatric otolaryngology patients with low health literacy, according to a research letter published online...
Heron Therapeutics Announces FDA Approval of an Indication Expansion for Zynrelef for Postoperative Pain Management
SAN DIEGO, Dec. 9, 2021 /PRNewswire/ – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class...
FDA Approves Zynrelef (bupivacaine and meloxicam) for the Management of Postoperative Pain
SAN DIEGO, May 13, 2021 /PRNewswire/ – Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class...
FDA Approves Posimir (bupivacaine) for Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ – DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Posimir (bupivacaine solution) for...
Ask a question
To post your own question to this support group, sign in or create an account.